Cargando…

Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China

OBJECTIVES: To examine the impact of demographic, socioeconomic, and behavioral factors on the development of cardiometabolic multimorbidity and mortality in Chinese elders. METHODS: Data from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) 2002–2018 was used in the study. Cardiometabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huihui, Duan, Xinyu, Rong, Peixi, Dang, Yusong, Yan, Mingxin, Zhao, Yaling, Chen, Fangyao, Zhou, Jing, Chen, Yulong, Wang, Duolao, Pei, Leilei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502033/
https://www.ncbi.nlm.nih.gov/pubmed/36158847
http://dx.doi.org/10.3389/fcvm.2022.966217
_version_ 1784795609856737280
author Zhang, Huihui
Duan, Xinyu
Rong, Peixi
Dang, Yusong
Yan, Mingxin
Zhao, Yaling
Chen, Fangyao
Zhou, Jing
Chen, Yulong
Wang, Duolao
Pei, Leilei
author_facet Zhang, Huihui
Duan, Xinyu
Rong, Peixi
Dang, Yusong
Yan, Mingxin
Zhao, Yaling
Chen, Fangyao
Zhou, Jing
Chen, Yulong
Wang, Duolao
Pei, Leilei
author_sort Zhang, Huihui
collection PubMed
description OBJECTIVES: To examine the impact of demographic, socioeconomic, and behavioral factors on the development of cardiometabolic multimorbidity and mortality in Chinese elders. METHODS: Data from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) 2002–2018 was used in the study. Cardiometabolic multimorbidity was defined as the presence of two or more cardiometabolic disorders, such as hypertension, diabetes, cardiovascular disease (CVD), heart disease, or stroke. Cox regression model and multi-state Markov model were developed to evaluate the association of the study factors with the progression of cardiometabolic conditions and mortality. The outcomes included three states (first cardiometabolic disease, cardiometabolic multimorbidity, and all-cause mortality) and five possible transitions among the three states. RESULTS: Of the 13,933 eligible individuals, 7,917 (56.8%) were female, and 9,540 (68.50%) were over 80 years old. 2,766 (19.9%) participants had their first cardiometabolic disease, 975 (7.0%) participants suffered from cardiometabolic multimorbidity, and 9,365 (67.2%) participants died. The progression to cardiometabolic multimorbidity was positively associated with being female (HR = 1.42; 95%CI, 1.10 − 1.85), living in the city (HR = 1.41; 95%CI, 1.04 − 1.93), overweight (HR = 1.43; 95%CI, 1.08 − 1.90), and obesity (HR = 1.75; 95% CI, 1.03 − 2.98). A higher risk for the first cardiometabolic disease was associated with being female (HR = 1.26; 95% CI, 1.15 − 1.39), higher socioeconomic status (SES, HR = 1.17; 95%CI, 1.07 − 1.28), lack of regular physical activity (HR = 1.13; 95%CI, 1.04 − 1.23), smoking (HR = 1.20; 95%CI, 1.08 − 1.33), ≤ 5 h sleep time (HR = 1.15; 95%CI, 1.02 − 1.30), overweight (HR = 1.48; 95% CI, 1.32 − 1.66), and obesity (HR = 1.34; 95%CI, 1.06 − 1.69). It also should be noted that not in marriage, lower SES and unhealthy behavioral patterns were risk factors for mortality. CONCLUSION: This study emphasized the importance of lifestyle and SES in tackling the development of cardiometabolic conditions among Chinese elders and provided a reference for policy-makers to develop a tailored stage-specific intervention strategy.
format Online
Article
Text
id pubmed-9502033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95020332022-09-24 Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China Zhang, Huihui Duan, Xinyu Rong, Peixi Dang, Yusong Yan, Mingxin Zhao, Yaling Chen, Fangyao Zhou, Jing Chen, Yulong Wang, Duolao Pei, Leilei Front Cardiovasc Med Cardiovascular Medicine OBJECTIVES: To examine the impact of demographic, socioeconomic, and behavioral factors on the development of cardiometabolic multimorbidity and mortality in Chinese elders. METHODS: Data from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) 2002–2018 was used in the study. Cardiometabolic multimorbidity was defined as the presence of two or more cardiometabolic disorders, such as hypertension, diabetes, cardiovascular disease (CVD), heart disease, or stroke. Cox regression model and multi-state Markov model were developed to evaluate the association of the study factors with the progression of cardiometabolic conditions and mortality. The outcomes included three states (first cardiometabolic disease, cardiometabolic multimorbidity, and all-cause mortality) and five possible transitions among the three states. RESULTS: Of the 13,933 eligible individuals, 7,917 (56.8%) were female, and 9,540 (68.50%) were over 80 years old. 2,766 (19.9%) participants had their first cardiometabolic disease, 975 (7.0%) participants suffered from cardiometabolic multimorbidity, and 9,365 (67.2%) participants died. The progression to cardiometabolic multimorbidity was positively associated with being female (HR = 1.42; 95%CI, 1.10 − 1.85), living in the city (HR = 1.41; 95%CI, 1.04 − 1.93), overweight (HR = 1.43; 95%CI, 1.08 − 1.90), and obesity (HR = 1.75; 95% CI, 1.03 − 2.98). A higher risk for the first cardiometabolic disease was associated with being female (HR = 1.26; 95% CI, 1.15 − 1.39), higher socioeconomic status (SES, HR = 1.17; 95%CI, 1.07 − 1.28), lack of regular physical activity (HR = 1.13; 95%CI, 1.04 − 1.23), smoking (HR = 1.20; 95%CI, 1.08 − 1.33), ≤ 5 h sleep time (HR = 1.15; 95%CI, 1.02 − 1.30), overweight (HR = 1.48; 95% CI, 1.32 − 1.66), and obesity (HR = 1.34; 95%CI, 1.06 − 1.69). It also should be noted that not in marriage, lower SES and unhealthy behavioral patterns were risk factors for mortality. CONCLUSION: This study emphasized the importance of lifestyle and SES in tackling the development of cardiometabolic conditions among Chinese elders and provided a reference for policy-makers to develop a tailored stage-specific intervention strategy. Frontiers Media S.A. 2022-09-09 /pmc/articles/PMC9502033/ /pubmed/36158847 http://dx.doi.org/10.3389/fcvm.2022.966217 Text en Copyright © 2022 Zhang, Duan, Rong, Dang, Yan, Zhao, Chen, Zhou, Chen, Wang and Pei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Zhang, Huihui
Duan, Xinyu
Rong, Peixi
Dang, Yusong
Yan, Mingxin
Zhao, Yaling
Chen, Fangyao
Zhou, Jing
Chen, Yulong
Wang, Duolao
Pei, Leilei
Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China
title Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China
title_full Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China
title_fullStr Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China
title_full_unstemmed Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China
title_short Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China
title_sort effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in china
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502033/
https://www.ncbi.nlm.nih.gov/pubmed/36158847
http://dx.doi.org/10.3389/fcvm.2022.966217
work_keys_str_mv AT zhanghuihui effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT duanxinyu effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT rongpeixi effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT dangyusong effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT yanmingxin effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT zhaoyaling effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT chenfangyao effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT zhoujing effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT chenyulong effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT wangduolao effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina
AT peileilei effectsofpotentialriskfactorsonthedevelopmentofcardiometabolicmultimorbidityandmortalityamongtheeldersinchina